Q2 EPS Estimates for Rigel Pharmaceuticals Cut by B. Riley
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – B. Riley cut their Q2 2025 earnings per share estimates for Rigel Pharmaceuticals in a report issued on Tuesday, May 6th. B. Riley analyst K. Patel now forecasts that the biotechnology company will post earnings of $0.14 per share for the quarter, down from their prior forecast […]
